[
  {
    "gene": {
      "hugoSymbol": "BRAF",
      "geneAliases": ["BRAF1", "RAFB1", "B-RAF"],
      "entrezGeneId": 673,
      "oncogene": true,
      "tsg": false,
      "grch37Isoform": "ENST00000288602",
      "grch38Isoform": "ENST00000288602"
    },
    "alteration": {
      "name": "V600E",
      "alteration": "V600E",
      "proteinStart": 600,
      "proteinEnd": 600,
      "refResidues": "V",
      "variantResidues": "E",
      "consequence": {
        "term": "missense_variant",
        "isGenerallyTruncating": false
      },
      "gene": "BRAF"
    },
    "treatments": [
      {
        "level": "1",
        "fdaLevel": "Fda2",
        "drugs": [
          {"drugName": "Vemurafenib", "ncitCode": "C64768"},
          {"drugName": "Dabrafenib", "ncitCode": "C82386"},
          {"drugName": "Encorafenib", "ncitCode": "C98831"}
        ],
        "indications": [
          {
            "tumorType": "Melanoma",
            "oncoTreeCode": "MEL",
            "mainType": "Melanoma"
          }
        ],
        "levelDescription": "FDA-approved therapy",
        "pmids": ["21639808", "22608338", "30219628"]
      },
      {
        "level": "2",
        "fdaLevel": null,
        "drugs": [
          {"drugName": "Dabrafenib", "ncitCode": "C82386"},
          {"drugName": "Trametinib", "ncitCode": "C77908"}
        ],
        "indications": [
          {
            "tumorType": "Non-Small Cell Lung Cancer",
            "oncoTreeCode": "NSCLC",
            "mainType": "Non-Small Cell Lung Cancer"
          }
        ],
        "levelDescription": "Standard care",
        "pmids": ["27283860"]
      }
    ],
    "oncogenic": "Oncogenic",
    "mutationEffect": "Gain-of-function",
    "mutationEffectPmids": ["12068308", "12231629"]
  },
  {
    "gene": {
      "hugoSymbol": "EGFR",
      "geneAliases": ["ERBB", "ERBB1", "HER1"],
      "entrezGeneId": 1956,
      "oncogene": true,
      "tsg": false,
      "grch37Isoform": "ENST00000275493",
      "grch38Isoform": "ENST00000275493"
    },
    "alteration": {
      "name": "L858R",
      "alteration": "L858R",
      "proteinStart": 858,
      "proteinEnd": 858,
      "refResidues": "L",
      "variantResidues": "R",
      "consequence": {
        "term": "missense_variant",
        "isGenerallyTruncating": false
      },
      "gene": "EGFR"
    },
    "treatments": [
      {
        "level": "1",
        "fdaLevel": "Fda2",
        "drugs": [
          {"drugName": "Osimertinib", "ncitCode": "C102567"},
          {"drugName": "Erlotinib", "ncitCode": "C65530"},
          {"drugName": "Gefitinib", "ncitCode": "C1855"}
        ],
        "indications": [
          {
            "tumorType": "Non-Small Cell Lung Cancer",
            "oncoTreeCode": "NSCLC",
            "mainType": "Non-Small Cell Lung Cancer"
          }
        ],
        "levelDescription": "FDA-approved therapy",
        "pmids": ["19692680", "28841975"]
      }
    ],
    "oncogenic": "Oncogenic",
    "mutationEffect": "Gain-of-function",
    "mutationEffectPmids": ["15696205", "16187797"]
  },
  {
    "gene": {
      "hugoSymbol": "TP53",
      "geneAliases": ["p53", "LFS1", "TRP53"],
      "entrezGeneId": 7157,
      "oncogene": false,
      "tsg": true
    },
    "alteration": {
      "name": "R175H",
      "alteration": "R175H",
      "proteinStart": 175,
      "proteinEnd": 175,
      "refResidues": "R",
      "variantResidues": "H",
      "consequence": {
        "term": "missense_variant",
        "isGenerallyTruncating": false
      },
      "gene": "TP53"
    },
    "treatments": [],
    "oncogenic": "Oncogenic",
    "mutationEffect": "Loss-of-function",
    "mutationEffectPmids": ["19847789", "8336941"]
  }
]
